Protective Role of High-Density Lipoprotein in Multiple Sclerosis.

Area of Science:

• Neuroimmunology
• Neuroinflammation
• Lipid Metabolism

Background:

• Multiple sclerosis (MS) is a chronic, progressive demyelinating and neurodegenerative disease with an autoimmune basis.
• Increased blood-brain barrier (BBB) permeability is a key factor in MS pathogenesis.
• Alterations in lipid profiles, particularly cholesterol metabolism, are increasingly recognized in MS patients.

Purpose of the Study:

• To review and summarize current research on the role of high-density lipoprotein (HDL) in multiple sclerosis.
• To highlight HDL's function as a mediator of anti-inflammatory responses in MS.
• To explore HDL's impact on BBB integrity and function in the context of MS.

Main Methods:

• Literature review of studies investigating lipid profiles in MS patients.
• Analysis of research on HDL's interaction with the endothelium and immune cells.
• Examination of HDL's effects on BBB permeability and inflammatory markers.

Main Results:

• Myelin destruction in MS leads to increased free cholesterol, disrupting lipid homeostasis.
• Evidence suggests HDL has a protective role by decreasing BBB permeability.
• HDL exerts anti-inflammatory effects by modulating adhesion molecules (VCAM-1, ICAM-1, E-selectin) and sphingosine-1-phosphate signaling, inhibiting leukocyte migration.

Conclusions:

• HDL plays a significant protective role in multiple sclerosis.
• HDL's anti-inflammatory properties and ability to reduce BBB permeability are crucial for its beneficial effects in MS.
• Targeting HDL may offer a therapeutic strategy for managing MS.